| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.1M | -15.4% | -36.4% |
| SG&A Expense | $1.9M | -31.4% | -31.8% |
| Operating Income | -$3.9M | +24.3% | +45.6% |
| Net Income | -$3.9M | +24.3% | +45.6% |
| EPS (Basic) | -$0.85 | +31.5% | -466.7% |
| EPS (Diluted) | -$0.85 | +31.5% | -466.7% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $11.8M | -14.4% | +75.6% |
| Total Assets | $16.8M | -13.4% | +5.0% |
| Current Liabilities | $1.7M | -12.8% | -53.1% |
| Total Liabilities | $3.6M | -13.4% | -51.5% |
| Stockholders' Equity | $13.2M | -13.5% | +53.6% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.6M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $10.1M | — | — |
| Free Cash Flow | -$10.6M | — | — |